NanoTemper’s Monolith wins top global design award: iF DESIGN AWARD 2021
April 15, 2021NanoTemper’s newest Monolith instrument has been awarded the globally renowned iF DESIGN AWARD 2021. User-friendly design has always been a core focus in NanoTemper’s product development. NanoTemper’s design approach — beyond thinking about aesthetics — puts the researcher’s needs at the center, ensuring that instruments not only solve big research challenges but also are intuitive and easy-to-use.
NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities
March 24, 2021NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets.
NanoTemper Technologies launches DLS capability with Prometheus Panta, bringing high-resolution, domain-specific stability characterization to biologics
September 24, 2020Prometheus, the new gold standard, now provides clarity to the most challenging stability characterizations
NanoTemper opens tech-forward demo facility in Japan showcasing new technology and offering hands-on experience
July 14, 2020Centrally located in the brand-new, swanky Minato Mirai Centre building in Yokohama Minato Mirai, Japan is NanoTemper Technologies’ newest tech-forward demo facility. Opened to support our distributor partnerships with Central Scientific Commerce (CSC) and M&S Technosystems (M&S), and to meet the growing demand for hands-on experience with our latest technologies for drug discovery, customers come for a personalized experience – to see live demos – and to learn about the most recent applications.
NanoTemper’s presence grows in China – Bigger office opens in Beijing
August 2, 2019We’re growing and thrilled to announce the expansion of our office in Beijing, China. Our mission is to enable everyone to do science that matters by always pushing the limits. Since our inception in 2008, we’ve been “pushing the limits” by going beyond our Munich-based beginnings to meet scientists where they are.
Answering the demands for a new screening tool for drug discovery with Dianthus
April 11, 2019There’s a gap that exists in screening tools for drug discovery — the need for fast, easy to use and flexible devices isn’t being satisfied. Enter Dianthus, introduced to come to the rescue.
NanoTemper Technologies Brings Speed to Drug Discovery Screening, Launches Dianthus System
January 31, 2019NanoTemper Technologies, maker of life science tools for protein characterization, launches its newest system, Dianthus, at the Society for Laboratory Automation and Screening (SLAS2019) conference in Washington, DC. Built to address the demands of drug discovery screening, Dianthus removes the complexity of binding interaction measurements and enables scientists to develop new drugs for every target faster and at lower costs.
Tycho named one of the Top 10 Innovations of 2018 by The Scientist
December 5, 2018We’re thrilled that Tycho is named one of the winners in The Scientist’s Top 10 Innovations of 2018 contest. We’re even further honored that the panel of independent judges — who represent the Broad Institute of MIT and Harvard and the Pacific Northwest National Laboratory — recognize Tycho’s contribution to assist researchers in doing better science.
NanoTemper named Growth Champions 2019
November 20, 2018We’re very excited to announce that FOCUS in cooperation with Statista has named NanoTemper as one of the top 500 fastest-growing companies in Germany! This 2019 Growth Champion Award recognizes companies with the highest sales growth during the years 2014 to 2017 and we’re so proud to have made the list.
NanoTemper named Growth Champions 2017 in Chemie and Pharma Category
December 7, 2016We have some great news! FOCUS and Statista have ranked the 500 fastest-growing companies in Germany and we made the list! They identified companies with exceptional growth rates between the years 2012 and 2015 as “Growth Champions 2017”. We’re proud to announce that NanoTemper Technologies met the qualification profile and ranked # 2 in the “Chemie und Pharma” category, with a growth rate of 65 % per year.